1-7 of 7
Otto Visser, MD
Close
Sort by
Journal Articles

Splenectomy Protects Humans from Red Cell Alloimmunization

Dorothea Evers, MD, Johanna G van der Bom, MD PhD, Janneke Tijmensen, MD, Masja de Haas, MD PhD Prof., Rutger A Middelburg, PhD, Karen de Vooght, PhD, Daan van de Kerkhof, PhD, Otto Visser, MD PhD, Nathalie Pequeriaux, MD, Fransisca Hudig, PhD, Jaap Jan Zwaginga, MD PhD
Journal: Blood
Blood (2016) 128 (22): 24.
https://doi.org/10.1182/blood.V128.22.24.24
Published: 2016
Journal Articles

CML Treatment in Dutch Hospitals with Low Patient Volumes Is Associated with a Substandard Quality of Molecular Response Monitoring

Inge G.P. Geelen, MD, Noortje Thielen, MD PhD, Jeroen J.W.M. Janssen, MD PhD, Tanja Roosma, Otto Visser, MD PhD, Jan J. Cornelissen, MD PhD, Peter E. Westerweel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1913.
https://doi.org/10.1182/blood.V128.22.1913.1913
Published: 2016
Journal Articles

The Immunogenicity of Red Blood Cell Antigens in Relation to Antigen Exposure

Dorothea Evers, MD, Rutger Middelburg, PhD, Masja De Haas, Prof, MD, Saurabh Zalpuri, MD PhD, Karen de Vooght, PhD, Daan van de Kerkhof, PhD, Otto Visser, MD PhD, Nathalie Pequeriaux, Francisca Hudig, PhD, Henk Schonewille, PhD, Jaap Jan Zwaginga, MD PhD, Anske van der Bom, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1139.
https://doi.org/10.1182/blood.V126.23.1139.1139
Published: 2015
Journal Articles

Trends in Incidence, Primary Treatment and Survival of Chronic Myelomonocytic Leukemia: A Nationwide Population-Based Study Among 1,359 Patients Diagnosed in the Netherlands from 1989 to 2012

Avinash G Dinmohamed, MSc, BASc, Mirian Brink, PhD, Otto Visser, MD PhD, Pieter Sonneveld, MDPhD, Arjan A van de Loosdrecht, MD PhD, Mojca Jongen-Lavrencic, MD PhD, Georgine E. de Greef, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4645.
https://doi.org/10.1182/blood.V124.21.4645.4645
Published: 2014
Journal Articles

Patterns of Primary Treatment, Trial Participation and Survival in Adult Acute Myeloid Leukemia: A Nationwide Population-Based Study Among Patients Diagnosed in the Netherlands from 1989 to 2012

Avinash G Dinmohamed, MSc, BASc, Otto Visser, MD PhD, Yvette van Norden, MSc, PhD, Nicole MA Blijlevens, MD PhD, Jan J. Cornelissen, MD PhD, Gerwin A Huls, MD PhD, Peter C Huijgens, MD PhD, Pieter Sonneveld, MDPhD, Arjan A van de Loosdrecht, MD PhD, Gert J Ossenkoppele, MD PhD, Bob Löwenberg, MD PhD, Mojca Jongen-Lavrencic, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2631.
https://doi.org/10.1182/blood.V124.21.2631.2631
Published: 2014
Journal Articles

Survival of Myeloid Malignancies in EUROPE: Results of the HAEMACARE Project.

Marc Maynadié, MD, PhD, Roberta De Angelis, Claudia Allemani, Riccardo Capocaccia, Jean Michel Lutz, Rafael Marcos Gragera, Carmen Tereanu, Otto Visser, MD, Milena Sant
Journal: Blood
Blood (2009) 114 (22): 3911.
https://doi.org/10.1182/blood.V114.22.3911.3911
Published: 2009
Journal Articles

No Harmful Impact of 90Yttrium-Ibritumomab Tiuxetan Combined with BEAM On Bone Marrow Microenvironment.

Otto Visser, MD, Floortje Kessler, Lars Perk, Maria Vosjan, Guus van Dongen, Josée Zijlstra, MD, PhD, Peter Huijgens, MD, PhD, Sonja Zweegman, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3538.
https://doi.org/10.1182/blood.V114.22.3538.3538
Published: 2009